Free Trial

GlycoMimetics (GLYC) SEC Filings & 10K Form

GlycoMimetics logo
$0.33 -0.05 (-13.16%)
(As of 11/20/2024 ET)

Recent GlycoMimetics SEC Filings

DateFilerForm TypeView
11/13/2024
3:30 PM
GlycoMimetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
3:42 PM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
3:47 PM
GlycoMimetics (Filer)
Form DEFA14A
11/06/2024
4:41 PM
GlycoMimetics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
11/04/2024
1:01 PM
GlycoMimetics (Subject)
Weinstein Benjamin (Filed by)
Form SCHEDULE 13G/A
10/29/2024
7:09 AM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:09 AM
GlycoMimetics (Filer)
Form DEFA14A
08/15/2024
4:01 PM
GlycoMimetics (Subject)
Invus Global Management, LLC (Filed by)
Form SC 13G/A
08/09/2024
3:30 PM
DEBBANE RAYMOND (Reporting)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:30 PM
DEBBANE RAYMOND (Reporting)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
4:16 PM
DEBBANE RAYMOND (Reporting)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
2:55 PM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
6:24 PM
GlycoMimetics (Subject)
Invus Global Management, LLC (Filed by)
Form SC 13G/A
07/29/2024
4:55 PM
DEBBANE RAYMOND (Reporting)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Siren, L.L.C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2024
3:29 PM
GlycoMimetics (Issuer)
Rock Edwin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:15 PM
GlycoMimetics (Issuer)
Hahn Brian M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
8:30 AM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
7:30 AM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
3:30 PM
GlycoMimetics (Issuer)
Koenig Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
7:25 AM
GlycoMimetics (Filer)
Form DEF 14A
04/01/2024
7:30 AM
GlycoMimetics (Filer)
Form ARS
03/27/2024
8:00 AM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
7:25 AM
GlycoMimetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/22/2024
4:00 PM
GlycoMimetics (Filer)
Form PRE 14A
03/01/2024
8:16 AM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
6:28 PM
GlycoMimetics (Subject)
NEW ENTERPRISE ASSOCIATES 10 L P (Filed by)
Form SC 13D/A
02/09/2024
4:03 PM
Artal International S.C.A. (Filed by)
GlycoMimetics (Subject)
Form SC 13G/A
01/29/2024
3:31 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
GlycoMimetics (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GLYC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners